RAC 4.00% $1.44 race oncology ltd

Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-128

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 19,420 Posts.
    lightbulb Created with Sketch. 6515
    Do many investors feel like they have to contribute to the strategic direction of the company or are they just trying to make suggestions that they think might be helpful?

    There have been two inputs from our shareholders that have had a major impact on the strategic direction of the company. The first was the discovery of the Su et al paper in 2020 by the late Graeme, and there was a second more recent one by another shareholder that I am not in a position to talk about. I would encourage all our shareholders to keep sharing their ideas and discoveries in the scientific literature with us - it is easier to spot something unusual when you have thousands of eyes looking, rather than just a handful of Race employees.

    I do wish more of our science educated shareholders were willing to share their knowledge publicly. I have spoken personally to more than a dozen of our science knowledgable shareholders and almost none of them ever post here or in any public forum. Scientists seem to be shy as a group.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.44
Change
-0.060(4.00%)
Mkt cap ! $245.4M
Open High Low Value Volume
$1.50 $1.50 $1.44 $57.11K 38.73K

Buyers (Bids)

No. Vol. Price($)
2 2499 $1.44
 

Sellers (Offers)

Price($) Vol. No.
$1.46 247 1
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.